Bernstein DI - Search Results

1

Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection.

Schleiss MR, Bourne N, Bravo FJ, Jensen NJ, Bernstein DI. Schleiss MR, et al. Among authors: bernstein di. J Virol Methods. 2003 Mar;108(1):103-10. doi: 10.1016/s0166-0934(02)00265-3. J Virol Methods. 2003. PMID: 12565160

2

Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.

Bernstein DI, Schleiss MR, Berencsi K, Gonczol E, Dickey M, Khoury P, Cadoz M, Meric C, Zahradnik J, Duliege AM, Plotkin S. Bernstein DI, et al. J Infect Dis. 2002 Mar 1;185(5):686-90. doi: 10.1086/339003. Epub 2002 Feb 6. J Infect Dis. 2002. PMID: 11865427 Clinical Trial.

3

Modification of primary and recurrent genital herpes in guinea pigs by passive immunization.

Bourne N, Pyles RB, Bernstein DI, Stanberry LR. Bourne N, et al. Among authors: bernstein di. J Gen Virol. 2002 Nov;83(Pt 11):2797-2801. doi: 10.1099/0022-1317-83-11-2797. J Gen Virol. 2002. PMID: 12388816

4

Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.

Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR. Bourne N, et al. Among authors: bernstein di. J Infect Dis. 2003 Feb 15;187(4):542-9. doi: 10.1086/374002. Epub 2003 Feb 7. J Infect Dis. 2003. PMID: 12599070

5

An animal model of neonatal cytomegalovirus infection.

Bravo FJ, Bourne N, Schleiss MR, Bernstein DI. Bravo FJ, et al. Among authors: bernstein di. Antiviral Res. 2003 Sep;60(1):41-9. doi: 10.1016/s0166-3542(03)00151-7. Antiviral Res. 2003. PMID: 14516920

6

Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.

Schleiss MR, Bourne N, Bernstein DI. Schleiss MR, et al. Among authors: bernstein di. J Infect Dis. 2003 Dec 15;188(12):1868-74. doi: 10.1086/379839. Epub 2003 Dec 9. J Infect Dis. 2003. PMID: 14673766

7

Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.

Schleiss MR, Bourne N, Stroup G, Bravo FJ, Jensen NJ, Bernstein DI. Schleiss MR, et al. Among authors: bernstein di. J Infect Dis. 2004 Apr 15;189(8):1374-81. doi: 10.1086/382751. Epub 2004 Apr 1. J Infect Dis. 2004. PMID: 15073673

8

Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects.

Schleiss MR, Bernstein DI, Passo M, Parker S, Meric C, Verdier F, Newkirk MM. Schleiss MR, et al. Among authors: bernstein di. Vaccine. 2004 Dec 16;23(5):687-92. doi: 10.1016/j.vaccine.2004.06.038. Vaccine. 2004. PMID: 15542191 Clinical Trial.

9

The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.

Schleiss MR, Bernstein DI, McVoy MA, Stroup G, Bravo F, Creasy B, McGregor A, Henninger K, Hallenberger S. Schleiss MR, et al. Among authors: bernstein di. Antiviral Res. 2005 Jan;65(1):35-43. doi: 10.1016/j.antiviral.2004.09.004. Antiviral Res. 2005. PMID: 15652969 Free PMC article.

10

Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.

Bravo FJ, Cardin RD, Bernstein DI. Bravo FJ, et al. Among authors: bernstein di. J Infect Dis. 2006 Feb 15;193(4):591-7. doi: 10.1086/499603. Epub 2006 Jan 13. J Infect Dis. 2006. PMID: 16425139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

600 results

Search Page

Filters